The American Society of Clinical Oncology (ASCO) just opened a guideline on chronic lymphocytic leukemia treatment to comment. The guideline, Initial Treatment for Chronic Lymphocytic Leukemia: ASCO Guideline, is available to view once interested individuals accept a confidentiality agreement.
Click here to view and accept the agreement required to view the guideline.
The public comment window is open through July 29, 2026.